Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters

Brain Research

Volumn 762, Issue 1-2, 1997, Pages 185-194

  Van Reeth, O ^a,b   Olivares, E ^a   Zhang, Y ^b   Zee, P C ^b   Mocaer, E ^c   Defrance, R ^c   Turek, F W ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b Depts Neurbio/Physiol Neurol N   (United States)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Agonist; Circadian; Clock; Melatonin; Mice; Rhythm; Syrian hamster

Indexed keywords

AGOMELATINE; MELATONIN; MELATONIN RECEPTOR; UNCLASSIFIED DRUG;

AGONIST; ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING SITE; LIGHT DARK CYCLE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER;

ACETAMIDES; ANIMALS; CIRCADIAN RHYTHM; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAPERITONEAL; MALE; MELATONIN; MESOCRICETUS; MICE; MICE, INBRED C3H; SPECIES SPECIFICITY;

EID: 0030850846     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00382-X     Document Type: Article

References (42)

1. Albers H.E., Ferris G.F. Neuropeptide Y: role in light-dark entrainment of hamster circadian rhythms. Neurosci. Lett. 50:1984;163-168.
2. Arendt J. Mammalian pineal rhythms. Adv. Pineal Res. 3:1985;161-214.
3. J. Arendt, Melatonin and the Pineal Gland, Chapman and Hall, London, 1995.
4. S.M. Armstrong, M.J. Chesworth, Melatonin phase-shifts a mammalian circadian clock, in: G.P. Trentini, C. De Gaetani, P. Pevet (Eds.), Fundamental and Clinics in Pineal Research, Raven Press, New York, 1987, pp. 195-198.
5. Benloucif S., Dubocovich M.L. Melatonin and light induce phase shifts of circadian activity rhythms in the C3H/HeN mouse. J. Biol. Rhythms. 11:1996;113-125.
6. E.L. Bittman, Melatonin and photoperiodic time measurement: evidence from rodents and ruminants, in: R.J. Reiter (Ed.), The Pineal Gland, Raven Press, New York, 1984, pp. 155-192.
7. C. Bonnefond, L. Martinet, D. Lesieur, G. Adam, B. Guardiola-Lemaître, Characterization of S-20098, a new melatonin analog, in: Y. Touitou, J. Arendt, P. Pevet (Eds.), Melatonin and the Pineal Gland, Elsevier, Amsterdam, 1993, pp. 123-126.
8. Daan S., Pittendrigh C.S. A functional analysis of circadian pacemakers in nocturnal rodents. II. The variability of phase responses curves J. Comp. Physiol. 106:1976;253-266.
9. W.W. Daniel, Applied Nonparametric Statistics, Houghton Mifflin Company, 1978.
10. Davis F.C., Mannion J. Entrainment of hamster pup circadian rhythms by prenatal melatonin injections to the mother. Am. J. Physiol. 255:1988;R439-R448.
11. Delagrange P., Guardiola B., Mason R. The effects of the new melatonin receptor agonist S-20098 on rat suprachiasmatic (SCN) neurones in vitro. Sleep Res. 22:1993;614.
12. Dubocovich M.L., Benloucif S., Masana M.I. Melatonin receptors in the mammalian suprachiasmatic nucleus. Behav. Brain Res. 73:1996;141-147.
13. Folkard S., Arendt J., Clark M. Can melatonin improve shift workers' tolerance to the night shift? Some preliminary findings. Chronobiol. Int. 10:1993;315-320.
14. Garfinkel D., Laudon M., Nof D., Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet. 346:1995;541-543.
15. Golombek D.A., Escolar E., Burin L., Brito Sanchez M.G., Cardinali D.P. Melatonin-induced depression of locomotor activity in hamsters: time-dependency and inhibition by the central type benzodiazepine antagonist Ro-151788. Physiol. Behav. 49:1991;1091-1098.
16. Golombek D.A., Escolar E., Burin L., Brito Sanchez M.G., Cardinali D.P. Chronopharmacology of melatonin: inhibition by benzodiazepine antagonism. Chronobiol. Int. 9:1992;124-131.
17. Hastings M.H., Mead S.M., Vindlacheruvu R.R., Ebling F.J.P., Maywood E.S., Grosse J. Non-photic phase shifting of the circadian activity rhythm of Syrian hamsters: the relative potency of arousal and melatonin. Brain Res. 591:1992;20-26.
18. B. Jones, M.G. Kenward, Design and Analysis of Cross-over Trials, Chapman and Hall, London, 1989.
19. K. Krauchi, C. Cajochen, A. Wirz-Justice, Melatonin and a melatonin agonist (S-20098) at 6 pm phase advance temperature, heart rate and dim light melatonin onset in parallel, Soc. Res. Biol. Rhythms Abstr. (1996) 69.
20. Lewy A.J., Ahmed S., Latham Jackson J.M., Sack R.L. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol. Int. 9:1992;380-392.
21. Martinet L., Guardiola-Lemaitre B., Mocaer E. Entrainment of circadian rhythm by S-20098 is dose and plasma concentration dependent. Pharmacol. Biochem. Behav. 54:1996;713-718.
22. Maywood E., Bittman E.L., Ebling F.J.P., Barrett P., Morgan P., Hastings M.H. Regional distribution of iodomelatonin binding sites within the suprachiasmatic nucleus of the Syrian hamster and the Siberian hamster. J. Neuroendocrinol. 7:1995;215-223.
23. E. Maywood, S.J. Hall, M.H. Hastings, Developmental changes in the distribution of iodomelatonin-binding sites in the SCN of the Syrian hamster and the rat, Soc. Res. Biol. Abstr. (1996) 84.
24. Maywood E., Hastings M.H. Lesions of the iodomelatonin-binding sites of the mediobasal hypothalamus spare the lactotropic, but block the gonadotropic response of male Syrian hamsters to short photoperiod and to melatonin. Endocrinology. 136:1995;144-153.
25. Oldani A., Ferini-Strambi L., Zucconi M., Stankov B., Fraschini F., Smirne S. Melatonin and delayed sleep phase syndrome: ambulatory polygraphic evaluation. Neuroreport. 6:1994;132-134.
26. Petrie K., Dawson A.G., Thomson L., Brook R. A double blind trial of melatonin as a treatment for jet lag in international cabin crew. Biol. Psychiatry. 33:1993;526-530.
27. Redman J., Armstrong S., Ng K.T. Free-running activity rhythms in the rat: entrainment by melatonin. Science. 219:1983;1089-1091.
28. J. Redman, B. Guardiola-Lemaître, The melatonin agonist S-20098: effects on the rat circadian system, in: Y. Touitou, J. Arendt, P. Pevet (Eds.), Melatonin and the Pineal Gland, Elsevier, Amsterdam, 1993, pp. 127-130.
29. Redman J.R., Armstrong S. Reentrainment of rat circadian activity rhythms: effects of melatonin. J. Pineal Res. 5:1988;203-215.
30. Redman J.R., Guardiola-Lemaitre B., Brown M., Delagrange P., Armstrong S.M. Dose-dependent effects of S-20098, a melatonin agonist, on direction and reentrainment of rat circadian rhythms. Psychopharmacology. 118:1995;385-390.
31. Sack R.L., Lewy A.L., Blood M.L., Stevenson J., Keith L.D. Melatonin administration to blind people: phase advances and entrainment. J. Biol. Rhythms. 6:1991;249-261.
32. R.R. Sokal, F.J. Rohlf, Biometry: the Principles and Practice of Statistics in Biomedical Research, Freeman, 1981.
33. Turek F.W. Pharmacological probes of the mammalian circadian clock: use of the phase response curve approach. Trends Pharmacol. Sci. 8:1987;212-217.
34. Turek F.W., Losee-Olson S. A benzodiazepine used in the treatment of insomnia phase-shifts the mammalian circadian clock. Nature. 321:1986;167-168.
35. Van Reeth O., Hinch D., Tecco J.M., Turek F.W. The effects of short periods of immobilization on the hamster circadian clock. Brain Res. 545:1991;208-214.
36. O. Van Reeth, D. Sawyers, R. Leproult, E. Olivares, G. Lapeyre, S-20098, a melatonin agonist, has hypothermic effects after single morning oral administration in humans, Soc. Res. Biol. Rhythms Abstr. (1994) 146.
37. Van Reeth O., Turek F.W. Stimulated activity mediates phase shifts in the hamster circadian clock induced by dark pulses or benzodiazepines. Nature. 339:1989;49-51.
38. Warren W.S., Hodges D.B., Cassone V.M. Pinealectomized rats entrain and phase shifts to melatonin injections in a dose-dependent manner. J. Biol. Rhythms. 8:1993;233-245.
39. D.R. Weaver, S.A. Rivkees, L.L. Carlson, S.M. Reppert, Localization of melatonin receptors in mammalian brain, in: D.C. Klein, R.Y. Moore, S.M. Reppert (Eds.), Suprachiasmatic Nucleus: the Mind's Clock, Oxford University Press, New York, 1991, pp. 289-308.
40. Ying S.W., Rusak B., Delagrange P., Mocaer E., Renard P., Guardiola-Lemaitre B. Melatonin analogues as agonist and antagonists in the circadian system and other brain areas. Eur. J. Pharmacol. 296:1996;33-42.
41. Yous S., Andrieux J., Howell H.E., Morgan P.J., Renard P., Pfeiffer B., Lesieur D., Guardiola-Lemaitre B. Novel naphthalenic ligands with affinity for the melatonin receptor. J. Med. Chem. 35:1992;1484-1485.
42. Zhdanova I.V., Wurtman R.J., Morabito C., Piotrovska V.R., Lynch H.J. Effects of low oral doses of melatonin, given 2-4 h before habitual bedtime, on sleep in normal humans. Sleep. 19:1996;423-431.